Top Markets
Coin of the day
Biora Therapeutics, Inc. Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

PROG
Rankning i aktier #27723
Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and... Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and commercialization of molecular diagnostic products within the United States. Its research and development efforts include targeted oral delivery systems for biotherapeutics, such as PGN-600, an oral liquid formulation of tofacitinib for ulcerative colitis, and PGN-001, an orally administered variant of adalimumab also targeting ulcerative colitis. Beyond this, the company is advancing systemic oral biotherapeutic delivery, exemplified by PGN-OB, which combines an adalimumab variant with their Oral Biotherapeutics Delivery System (OBDS) for inflammatory conditions, and PGN-OB2, pairing a GLP-1 receptor agonist with the OBDS for Type 2 diabetes. Biora Therapeutics also creates innovative diagnostic tools, including the Recoverable Sampling System – an ingestible smart capsule engineered to autonomously locate, collect, and preserve samples from the GI tract for analysis – and PIL Dx, another ingestible smart capsule designed to sample, measure, and transmit data wirelessly. A collaboration with Ionis Pharmaceuticals is underway to assess the OBDS platform for delivering antisense oligonucleotides. Founded in 2010 as Ascendant MDX, Inc., the company adopted the name Progenity, Inc. in November 2013, prior to becoming Biora Therapeutics, Inc. Its headquarters are located in San Diego, California.
Aktiekurs
$0.8845
Senast synkroniserad: 2022-05-06
Marknadsvärde
$31.01M
Förändring (1 dag)
-3.47%
Förändring (1 år)
0.00%
Land
US
Handel Biora Therapeutics, Inc. (PROG)

Kategori

Antal utestående aktier för Biora Therapeutics, Inc. (PROG)
Antal utestående aktier per August 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för Biora Therapeutics, Inc. är det aktuella antalet utestående aktier 0. I slutet av August 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Biora Therapeutics, Inc. (PROG) från 2026 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
Inte tillräckligt med data för de angivna datumen.
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
253.90M -
US
396.00M -
US
62.19M -
NL
483.58M -
AU
- -
CH